Article ID Journal Published Year Pages File Type
8233043 International Journal of Radiation Oncology*Biology*Physics 2010 7 Pages PDF
Abstract
Our data suggest that lapatinib combined with fractionated radiotherapy may be useful against EGFR+ and HER2+ breast cancers and that inhibition of downstream signaling to ERK1/2 and AKT correlates with sensitization in EGFR+ and HER2+ cells, respectively.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts
Authors
, , , , , , , ,